Premium
Enanta Pharmaceuticals Inc (ENTA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Janus Henderson Group plc | Institution | 3 784 055 | 13,01% | US$ 42,68M | 2026-03-31 |
| BlackRock, Inc. | Institution | 3 103 768 | 10,67% | US$ 35,01M | 2026-03-31 |
| Janus Henderson Biotech Innovation Master Fund Limited | Institution | 2 959 525 | 10,18% | US$ 33,38M | 2025-10-31 |
| Farallon Capital Management, L.L.C. | Institution | 2 871 862 | 9,88% | US$ 32,39M | 2026-03-31 |
| Krensavage Asset Management, LLC | Institution | 2 866 138 | 9,86% | US$ 32,33M | 2026-03-31 |
| Deep Track Capital, LP | Institution | 1 956 867 | 6,73% | US$ 22,07M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 1 484 513 | 5,11% | US$ 16,75M | 2025-10-02 |
| Vanguard Capital Management, LLC | Institution | 1 178 049 | 4,05% | US$ 13,29M | 2026-03-31 |
| Farallon Capital Offshore Investors II, L.P | Institution | 1 110 733 | 3,82% | US$ 12,53M | 2025-12-31 |
| Vanguard Portfolio Management, LLC | Institution | 948 904 | 3,26% | US$ 10,70M | 2026-03-31 |
| Spruce Street Capital LP | Institution | 932 598 | 3,21% | US$ 10,52M | 2026-03-31 |
| Millennium Management LLC | Institution | 882 097 | 3,03% | US$ 9,95M | 2026-03-31 |
| Acadian Asset Management LLC | Institution | 880 023 | 3,03% | US$ 9,93M | 2026-03-31 |
| Dr. Jay Luly | Initiés | 856 121 | 2,94% | US$ 9,66M | 2026-02-12 |
| Geode Capital Management, LLC | Institution | 725 061 | 2,49% | US$ 8,18M | 2026-03-31 |
| Integrated Core Strategies (US) LLC | Institution | 665 953 | 2,29% | US$ 7,51M | 2025-12-31 |
| Renaissance Technologies LLC | Institution | 665 258 | 2,29% | US$ 7,50M | 2026-03-31 |
| Farallon Capital Institutional Partners, L.P. | Institution | 595 851 | 2,05% | US$ 6,72M | 2025-12-31 |
| State Street Global Advisors, Inc. | Institution | 562 106 | 1,93% | US$ 6,34M | 2026-03-31 |
| Farallon Capital Partners, L.P. | Institution | 531 119 | 1,83% | US$ 5,99M | 2025-12-31 |
| Hillsdale Investment Management Inc. | Institution | 435 510 | 1,50% | US$ 4,91M | 2026-03-31 |
| Dr. Yat Or | Initiés | 369 604 | 1,27% | US$ 4,17M | 2026-02-12 |
| AQR Capital Management, LLC | Institution | 302 121 | 1,04% | US$ 3,41M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 294 971 | 1,01% | US$ 3,33M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 267 364 | 0,92% | US$ 3,02M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 262 533 | 0,90% | US$ 2,96M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 240 968 | 0,83% | US$ 2,72M | 2026-03-31 |
| Goldman Sachs Asset Management, L.P. | Institution | 210 793 | 0,72% | US$ 2,38M | 2026-03-31 |
| Marshall Wace LLP | Institution | 210 070 | 0,72% | US$ 2,37M | 2026-03-31 |
| Eaton Vance Management | Institution | 208 521 | 0,72% | US$ 2,35M | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 203 252 | 0,70% | US$ 2,29M | 2026-03-31 |
| Farallon Capital F5 Master I, L.P. | Institution | 176 083 | 0,61% | US$ 1,99M | 2025-12-31 |
| Vanguard Fiduciary Trust Company | Institution | 175 856 | 0,60% | US$ 1,98M | 2026-03-31 |
| Invesco Capital Management LLC | Institution | 156 007 | 0,54% | US$ 1,76M | 2026-03-31 |
| Farallon Capital Institutional Partners II, L.P. | Institution | 150 355 | 0,52% | US$ 1,70M | 2025-12-31 |
| Connor, Clark & Lunn Investment Management Ltd. | Institution | 125 759 | 0,43% | US$ 1,42M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
